Literature DB >> 28182567

Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013.

Patompong Ungprasert1, Cynthia S Crowson2,3, Eric L Matteson2,4.   

Abstract

A higher incidence of cardiovascular disease (CVD) has been observed in several chronic inflammatory diseases. However, data on sarcoidosis are limited.In this study, 345 patients with incident sarcoidosis in Olmsted County (Minnesota, USA) during 1976-2013 were identified based on comprehensive medical record review. 345 sex- and age-matched comparators were also identified from the same underlying population. Medical records were individually reviewed for CVD, including coronary artery disease, congestive heart failure, atrial fibrillation, cerebrovascular accident, transient ischaemic attack, peripheral arterial disease and abdominal aortic aneurysm. Cox proportional hazards models with adjustment for age, sex, calendar year and cardiovascular risk factors were used to compare the rate of development of CVD between cases and comparators.The prevalence of CVD before the index date was not significantly different between the two groups. Adjusting for age, sex and calendar year, the risk of incident CVD after the index date was significantly elevated among patients with sarcoidosis with an adjusted hazard ratio of 1.57 (95% CI 1.15-2.16). Adjustment for cardiovascular risk factors yielded an adjusted hazard ratio of 1.65 (95% CI 1.08-2.53). Significantly increased risk was also observed for several types of CVD, including coronary artery disease, congestive heart failure, atrial fibrillation and cerebrovascular accident.Increased incidence of CVD among patients with sarcoidosis was demonstrated in this population-based cohort, even after controlling for baseline traditional atherosclerotic risk factors.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28182567      PMCID: PMC5564441          DOI: 10.1183/13993003.01290-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

Review 2.  Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Promporn Suksaranjit; Ittikorn Spanuchart; Napat Leeaphorn; Nitipong Permpalung
Journal:  Semin Arthritis Rheum       Date:  2014-03-06       Impact factor: 5.532

Review 3.  Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.

Authors:  F Montecucco; F Mach
Journal:  Rheumatology (Oxford)       Date:  2008-10-16       Impact factor: 7.580

Review 4.  Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.

Authors:  B A Rybicki; M Major; J Popovich; M J Maliarik; M C Iannuzzi
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

5.  Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase.

Authors:  T B Rajavashisth; J K Liao; Z S Galis; S Tripathi; U Laufs; J Tripathi; N N Chai; X P Xu; S Jovinge; P K Shah; P Libby
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 6.  Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects.

Authors:  Joseph V Moxon; Adam Parr; Theophilus I Emeto; Philip Walker; Paul E Norman; Jonathan Golledge
Journal:  Curr Probl Cardiol       Date:  2010-10       Impact factor: 5.200

Review 7.  Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation.

Authors:  Nicoletta Riva; Marco P Donadini; Walter Ageno
Journal:  Thromb Haemost       Date:  2014-12-04       Impact factor: 5.249

Review 8.  Inflammation, innate immunity and blood coagulation.

Authors:  J Xu; F Lupu; C T Esmon
Journal:  Hamostaseologie       Date:  2010-01       Impact factor: 1.778

9.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

10.  Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  14 in total

1.  Association between sarcoidosis, pulse wave velocity, and other measures of subclinical atherosclerosis: a systematic review and meta-analysis.

Authors:  Wai Chung Yong; Anawin Sanguankeo; Sikarin Upala
Journal:  Clin Rheumatol       Date:  2017-11-25       Impact factor: 2.980

Review 2.  Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Reumatismo       Date:  2017-05-22

3.  Inpatient Prevalence, Expenditures, and Comorbidities of Sarcoidosis: Nationwide Inpatient Sample 2013-2014.

Authors:  Patompong Ungprasert; Karn Wijarnpreecha; Wisit Cheungpasitporn; Charat Thongprayoon; Wuttiporn Manatsathit; Paul T Kröner
Journal:  Lung       Date:  2019-02-23       Impact factor: 2.584

4.  Cardiac conduction disturbances in rheumatologic disease: a cross-sectional study.

Authors:  Louis Gerges; Kyla D'Angelo; David Bass; Arezoo Haghshenas; Daniel J Kersten; Manmeet Ahluwalia; Roman Zelster; Amgad N Makaryus
Journal:  Am J Cardiovasc Dis       Date:  2022-02-15

5.  Association between sarcoidosis and cardiovascular Outcomes: A systematic review and Meta-analysis.

Authors:  Vikash Jaiswal; Song Peng Ang; Zouina Sarfraz; Swatika Butey; Harshwardhan Vinod Khandait; David Song; Jia Ee Chia; Dipansha Maroo; Muhammad Hanif; Mohammed Ghanim; Raja Chand; Monodeep Biswas
Journal:  Int J Cardiol Heart Vasc       Date:  2022-06-29

6.  Increased Risk of Multimorbidity in Patients With Sarcoidosis: A Population-Based Cohort Study 1976 to 2013.

Authors:  Patompong Ungprasert; Eric L Matteson; Cynthia S Crowson
Journal:  Mayo Clin Proc       Date:  2017-11-03       Impact factor: 7.616

Review 7.  Epidemiology of sarcoidosis: current findings and future directions.

Authors:  Elizabeth V Arkema; Yvette C Cozier
Journal:  Ther Adv Chronic Dis       Date:  2018-08-24       Impact factor: 5.091

8.  Heart Failure, Atrioventricular Block, and Ventricular Tachycardia in Sarcoidosis.

Authors:  David G Rosenthal; Christina D Fang; Christopher A Groh; Gregory Nah; Eric Vittinghoff; Thomas A Dewland; Vasanth Vedantham; Gregory M Marcus
Journal:  J Am Heart Assoc       Date:  2021-02-18       Impact factor: 5.501

9.  Sarcoidosis mortality in Sweden: a population-based cohort study.

Authors:  Marios Rossides; Susanna Kullberg; Johan Askling; Anders Eklund; Johan Grunewald; Elizabeth V Arkema
Journal:  Eur Respir J       Date:  2018-02-21       Impact factor: 16.671

Review 10.  Clinical Features and Diagnosis of Cardiac Sarcoidosis.

Authors:  Claudio Tana; Cesare Mantini; Iginio Donatiello; Luciano Mucci; Marco Tana; Fabrizio Ricci; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.